SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Milich D.R. (1997) Pathobiology of acute and chronic hepatitis B virus infection: an introduction. J Viral Hepat 4: 2530.
  • 2
    Akbar S.M., Onji M., Inaba K., Yamamura K.I., Ohta Y. (1993) Low responsiveness of hepatitis B virus-transgenic mice in antibody response to T-cell-dependent antigen: defect in antigen-presenting activity of dendritic cells. Immunology 78: 46875.
  • 3
    Kurose K., Akbar S.M., Yamamoto K., Onji M. (1997)Production of antibody to hepatitis B surface antigen (anti-HBs) by murine hepatitis B virus carriers: neonatal tolerance versus antigen presentation by dendritic cells. Immunology 92: 494500.
  • 4
    Banchereau J., Steinman R.M. (1998) Dendritic cells and the control of immunity. Nature 392: 24552.
  • 5
    Pulendran B., Tang H., Denning T.L. (2008) Division of labor, plasticity, and crosstalk between dendritic cell subsets. Curr Opin Immunol 20: 617.
  • 6
    Cella M., Pinet Engering A., Pieters J., Lanzavecchia A. (1997) Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388: 7827.
  • 7
    Jochum C., Voth R., Rossol S. (1990) Immunosuppressive function of hepatitis B antigens in vitro: role of endoribonuclease V as one potential trans inactivator for cytokines in macrophages and human hepatoma cells. J Virol 64: 195663.
  • 8
    Kocabas C.N. (2001) Do hepatitis B virus carriers develop atopic diseases? Allergy 56: 11001.
  • 9
    Uter W., Stock C., Pfahlberg A. (2003) Association between infections and signs and symptoms of ‘atopic’ hypersensitivity–results of a cross-sectional survey among first-year university students in Germany and Spain. Allergy 58: 5804.
  • 10
    Akbar F., Abe M., Masumoto T., Horiike N., Onji M. (1999) Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dentritic cells. J Hepatol 30: 75564.
  • 11
    Bian G., Cheng Y., Wang Z., Hu Y., Zhang X., Wu M., Chen Z., Shi B., Sun S., Shen Y., Chen E.J., Yao X., Wen Y., Yuan Z. (2009) Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses. Vaccine 28: 18794.
  • 12
    Suen J.L., Chuang Y.H., Chiang B.L. (2002) In vitro tolerance breakdown with dendritic cells pulsed with U1A protein in non-autoimmune mice: the induction of a high level of autoantibodies but not renal pathological changes. Immunology 106: 32635.
  • 13
    Sher A., Coffman R.L. (1992) Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol 10: 385409.
  • 14
    Mosmann T.R., Coffman R.L. (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7: 14573.
  • 15
    Chang M.H., Chen C.J., Lai M.S., Hsu H.M., Wu T.C., Kong M.S. (1997) Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 336: 18559.
  • 16
    Lee C.Y., Hung L.M., Chang M.H., Hsu C.Y., Wu S.J., Sung J.L. (1991) The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothers. Pediatr Infect Dis J 10: 299303.
  • 17
    Vitiello A., Ishioka G., Grey H.M. (1995) Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. Induction of a primary cytotoxic T lymphocyte response in humans. J Clin Invest 95: 3419.
  • 18
    Akbar S.M.F., Kajino K., Tanimoto T., Kurose K., Masumoto T., Michitaka K. (1997) Placebo-controlled trial of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice. J Hepatol 26: 1317.
  • 19
    Roake J.A., Rao A.S., Morris P.J., Larsen C.P., Hankins D.F., Austyn J.M. (1995) Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J Exp Med 181: 223747.
  • 20
    Sallusto F., Cella M., Danieli C., Lanzavecchia A. (1995) Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182: 389400.
  • 21
    O'Sullivan B.J., Thomas R. (2002) CD40 ligation conditions dendritic cell antigen-presenting function through sustained activation of NF-B. J Immunol 168: 54918.
  • 22
    Lin Y.L., Liang Y.C., Lee S.S., Chiang B.L. (2005) Polysaccharide purified from Ganoderma lucidum induced activation and maturation of human monocyte-derived dendritic cells by the NF-kB and p38 mitogen-activated protein kinase pathways. J Leukoc Biol 78: 53343.
  • 23
    Macatonia S.E., Hosken N.A., Litton M. (1995) Dendritic cells produce IL-12 and direct the development of Th1 cells from naïve CD4+ T cells. J Immunol 154: 50719.
  • 24
    Trinchieri G. (1998) Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv Immunol 70: 83243.
  • 25
    Sinigaglia F., D’Ambrosio D., Panina-Bordignon P., Rogge L. (1999) Regulation of the IL-12/IL-12R axis: a critical step in T-helper cell differentiation and effector function. Immunol Rev 170: 6572.
  • 26
    Hsieh C.S., Macatonia S.E., Tripp C.S., Wolf S.F., O’Garra A., Murphy K.M. (1993) Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260: 5479.
  • 27
    Hendrzak J.A., Brunda M.J. (1995) Interleukin-12. Biologic activity, therapeutic utility, and role in disease. Lab Invest 72: 61937.
  • 28
    Galon J., Sudarshan C., Ito S., Finbloom D., O'Shea J.J. (1999) IL-12 induces IFN regulating factor-1 (IRF-1) gene expression in human NK and T cells. J Immunol 162: 725662.
  • 29
    Biron C.A., Nguyen K.B., Pien G.C. Cousens L.P., Salazar-Mather T.P. (1999) Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17: 189220.
  • 30
    Fang S.H., Hwang L.H., Chen D.S., Chiang B.L. (2003) Ribavirin enhancement of hepatitis C virus core antigen-specific type 1 T helper cell response correlates with the increased IL-12 level. J Hepatol 33: 7918.
  • 31
    Lin Y.L., Lee S.S., Hou S.M., Chiang B.L. (2006) Polysaccharide purified from Ganoderma lucidum induces gene expression changes in human dendritic cells and promotes Th1 immune response in BALB/c mice. Mol Pharmacol 70: 63744.
  • 32
    Schirmbeck R., Reimann J. (2002) Alternative processing of endogenous or exogenous antigens extends the immunogenic, H-2 class I-restricted peptide repertoire. Mol Immunol 39: 24959.
  • 33
    Safadi R., Israeli E., Papo O., Shibolet O., Melhem A., Bloch A. (2003) Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins. Am J Gastroenterol 98: 250515.
    Direct Link:
  • 34
    Milich D.R., Schodel F., Peterson D.L. (1995) Characterization of self-reactive T cells that evade tolerance in hepatitis B e antigen transgenic mice. Eur J Immunol 25: 166372.